PSTX - Poseida spikes after FDA orphan status for CAR-T therapy March, 13 2024 08:22 AM Poseida Therapeutics Inc. 2024-03-13 08:22:59 ET More on Poseida Therapeutics Poseida Therapeutics: Non-Self CAR T Looks To Be Safe And Potentially Impactful Seeking Alpha’s Quant Rating on Poseida Therapeutics Historical earnings data for Poseida Therapeutics Financial information for Poseida Therapeutics For further details see: Poseida spikes after FDA orphan status for CAR-T therapy